➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Dow
Mallinckrodt
Baxter
AstraZeneca

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Patent: 7,722,857

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,722,857
Title:Immunoadjuvant
Abstract: An immunoadjuvant comprising one kind or two or more kinds of immunostimulating substances carried separately by two or more kinds of different microparticle immunostimulating substance carriers, and comprising at least a combination of (a) an inorganic substance such as microparticle calcium phosphate having a size phagocytizable by cells, and (b) precipitates of a soluble protein and a mucopolysaccharide formed by coacervation as the microparticle immunostimulating substance carriers, which is highly safe and can exhibit potent immunoadjuvant activity.
Inventor(s): Ohno; Tadao (Ibaraki, JP), Uchimura; Eiji (Chiba, JP)
Assignee: Cell-Medicine, Inc. (Ibaraki, JP)
Application Number:12/159,907
Patent Claims:see list of patent claims

Details for Patent 7,722,857

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
A-s Medication Solutions TUBERSOL tuberculin purified protein derivative INJECTION, SOLUTION 103941 1 1956-08-15   Start Trial Cell-Medicine, Inc. (Ibaraki, JP) 2040-01-28 search
Par Pharmaceutical, Inc. APLISOL tuberculin purified protein derivative INJECTION 103782 1 2008-04-25   Start Trial Cell-Medicine, Inc. (Ibaraki, JP) 2040-01-28 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
Dow
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.